SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0000950144-08-006184
Filing Date
2008-08-07
Accepted
2008-08-07 17:22:30
Documents
7
Period of Report
2008-06-30
Filing Date Changed
2008-08-07

Document Format Files

Seq Description Document Type Size
1 KING PHARMACEUTICALS, INC. - FORM 10-Q g14246e10vq.htm 10-Q 1186052
2 EX-10.1 PRODUCT DEVELOPMENT AGREEMENT g14246exv10w1.htm EX-10.1 125870
3 EX-10.2 DIRECTOR COMPENSATION POLICY g14246exv10w2.htm EX-10.2 11341
4 EX-31.1 SECTION 302 CERTIFICATION OF THE CEO g14246exv31w1.htm EX-31.1 9169
5 EX-31.2 SECTION 302 CERTIFICATION OF THE CFO g14246exv31w2.htm EX-31.2 9161
6 EX-32.1 SECTION 906 CERTIFICATION OF THE CEO g14246exv32w1.htm EX-32.1 3790
7 EX-32.2 SECTION 906 CERTIFICATION OF THE CFO g14246exv32w2.htm EX-32.2 3782
  Complete submission text file 0000950144-08-006184.txt   1350532
Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Filer) CIK: 0001047699 (see all company filings)

IRS No.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15875 | Film No.: 08999613
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1